Published: 29.03.2019, updated: 29.03.2019
About one third of Norwegian women do not attend screening against cervical cancer as often as recommended by the Norwegian Cervical Cancer Screening Program (NCCSP). Minority women and women currently outside of the workforce are overrepresented among under-screened women. Thus, it is important to obtain more knowledge on how to overcome barriers to cervical cancer screening faced by under-screened women.
Can self-sampling tests increase screening attendance?
In this study, we will examine whether a self-sampling Human Papillomavirus (HPV) test can increase attendance to cervical cancer screening among women who have not been screened for at least ten years. Furthermore, we aim to assess whether self-sampling may reduce social inequity in screening attendance.
We will perform a randomized control trial (RCT), and compare the screening attendance among women who receive (i) the usual reminder from NCCSP to be screened, (ii) a self-sampling test in the mail, and (iii) an offer to order a self-sampling test. 6000 randomly selected women between the ages of 35 to 69 who have not been screened for cervical cancer for at least a decade will be invited to participate in the study.
In addition, we assess the best follow-up method for women with a positive HPV test result. Half of the HPV-positive women will be referred to a gynaecologist whereas the other half will receive a follow-up appointment with their regular general practitioner (GP).
The self-sampling test will only be offered to women who are invited to participate in the study.The study on the use of cervical self-sampling will start in March 2019.
If you have received an invitation to order a self-sampling test, you can order it here.
If you have any questions regarding the self-sampling test or the study, please contact us by mail to email@example.com or by phone: 22928941/ 22928919.
What are the barriers to cervical cancer screening?
In the first part of the project we carried out a qualitative study where we interviewed long-term non-attending women about their views on cervical cancer screening. We have completed the interviews for this study and are currently working on analysing and publishing the result.
Cancer Registry of Norway
Bo Terning Hansen, Gunvor Aasbø, Ameli Tropé, Karina Undem and Mari Nygård.
University College London: Jo Waller
University of Oslo: Kari Nyheim Solbrække
Albert Einstein College of Medicine: Philip Castle
University of Bergen: Tone Bjørge
Akershus University Hospital: Irene Kraus Christiansen
The project is financed by The Norwegian cancer Society and Thea Steens memorial fund.